These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 3458672)
21. Diphenylhydantoin-induced gingival hyperplasia: its response to changes in drug dosage. Little TM; Girgis SS; Masotti RE Dev Med Child Neurol; 1975 Aug; 17(4):421-4. PubMed ID: 1158048 [TBL] [Abstract][Full Text] [Related]
22. [Case of gingival hyperplasia due to diphenylhydantoin]. Bella G; Rossetti B; Greco S; Indelicato F Minerva Stomatol; 1987 May; 36(5):367-71. PubMed ID: 3476825 [No Abstract] [Full Text] [Related]
23. [On the pathomechanism of hydantoin-induced gingival hyperplasia]. Terner K; Tornai A; Tóth S Fogorv Sz; 1968 Aug; 61(8):228-34. PubMed ID: 5245442 [No Abstract] [Full Text] [Related]
24. [Current trends in periodontology. Hypertrophic-hyperplastic gingivopathy due to diphenylhydantoin]. Weinstein R Mondo Odontostomatol; 1986; 28(2):81-6. PubMed ID: 3462493 [No Abstract] [Full Text] [Related]
25. Gingival hyperplasia of an edentulous alveolar ridge in an epileptic--a case report. Darling MR; Arendorf TM; Shaikh AB; Stephen LX N Z Dent J; 1988 Oct; 84(378):114-6. PubMed ID: 3185996 [No Abstract] [Full Text] [Related]
26. Diphenylhydantoin-induced gingival hyperplasia: its relationship to dose and serum level. Kapur RN; Girgis S; Little TM; Masotti RE Dev Med Child Neurol; 1973 Aug; 15(4):483-7. PubMed ID: 4732898 [No Abstract] [Full Text] [Related]
30. Incidence of phenytoin induced gingival overgrowth in epileptic children: a six month evaluation. Prasad VN; Chawla HS; Goyal A; Gauba K; Singhi P J Indian Soc Pedod Prev Dent; 2002 Jun; 20(2):73-80. PubMed ID: 12435021 [TBL] [Abstract][Full Text] [Related]
31. Diphenylhydantoin gingival hyperplasia. A clinicopathological review. 1. Incidence, clinical features and histopathology. Angelopoulos AP Dent J; 1975 Feb; 41(2):103-6. PubMed ID: 1089674 [No Abstract] [Full Text] [Related]
32. The oxytalan connective tissue fibres in gingival hyperplasia in patients treated with sodium diphenylhydantoin. Baratieri A J Periodontal Res; 1967; 2(2):106-14. PubMed ID: 4229978 [No Abstract] [Full Text] [Related]
33. [Gingival hyperplasia due to diphenylhydantoin. Anatomo-clinical study of a case]. Latorre G; Carrozza G; Busà S; Calabrò S; Briguglio R Stomatol Mediterr; 1986; 6(4):483-8. PubMed ID: 2955528 [No Abstract] [Full Text] [Related]
34. [Hyperplasia caused by diphenylhydantoin in patients with and without teeth (II)]. Dreyer WP; Thomas CJ Med Hyg (Geneve); 1982 Mar; 40(1461):932-4. PubMed ID: 6955585 [No Abstract] [Full Text] [Related]
35. Therapeutic alternatives in phenytoin-induced gingival hyperplasia. A case report and discussion. Reynolds NC; Kirkham DB J Periodontol; 1980 Sep; 51(9):516-20. PubMed ID: 6775072 [TBL] [Abstract][Full Text] [Related]
37. A clinicopathological review. Diphenylhydantoin gingival hyperplasia: 2. Aetiology, pathogenesis, differential diagnosis and treatment. Angelopoulos AP Dent J; 1975 May; 41(5):275-7, 283. PubMed ID: 1055114 [No Abstract] [Full Text] [Related]
38. [Oral hygiene in subjects treated with diphenylhydantoin: effects of a professional program]. Francetti L; Maggiore E; Marchesi A; Ronchi G; Romeo E Prev Assist Dent; 1991; 17(3):40-3. PubMed ID: 1946070 [TBL] [Abstract][Full Text] [Related]
39. Management of gingival hyperplasia in patients receiving Dilantin therapy. Ginwalla TM; Gomes GC; Nayak RP J Indian Dent Assoc; 1967 Aug; 39(8):124-6. PubMed ID: 5236651 [No Abstract] [Full Text] [Related]